Prospect News: News for Neuraxpharm Holdco Sarl

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with N > Issuers starting with N, BK only > All stories on Neuraxpharm Holdco Sarl > Stories on Neuraxpharm Holdco Sarl, BK only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Neuraxpharm Holdco Sarl

7/8/2025	BK	S&P sees Neuraxpharm negatively
10/23/2020	BK	Moody’s rates Neuraxpharm, loans B3
1/17/2020	BK	S&P assigns B to Neuraxpharm, loan
1/16/2020	BK	S&P cuts Dealer Tire
1/16/2020	BK	Moody’s rates Neuraxpharm, loan B3

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.